Nevada Mental Health recently expanded its ketamine therapy program, which is part of the interventional psychiatry program.
A federal court in Los Angeles sentenced Kenneth Iwamasato and Jasveen Sengha to prison sentences for their roles in “Friends” actor Matthew Perry’s accidental ketamine overdose death. In all, five people received prison sentences for their links to Perry’s death.
The U.S. Food and Drug Administration has approved ketamine as an anesthetic.
Unsupervised or recreational ketamine use carries overdose risks. But when administered in small therapeutic doses by licensed psychiatrists, as in Nevada Mental Health’s ketamine therapy program, ketamine therapy can help treat major depression, suicidal ideation and post-traumatic stress disorder-related trauma symptoms.
Nevada Mental Health’s ketamine therapies include esketamine, sold under the brand name Spravato, an FDA-approved, prescription-only nasal spray for treating adults with treatment-resistant depression. The drug targets glutamate, a brain chemical, to help cells communicate and form new pathways and reduce symptoms quickly.
“We’ve all heard of ketamine, but just because a medication can be abused doesn’t mean it doesn’t have positive benefits and effects when used in the right amounts and in the right scenarios,” Nevada Mental Health co-founder and psychiatrist Dr. Timothy Jeider said. “Nevada Mental Health offers therapy-assisted ketamine treatment, where the medication is given and the patient receives a talk-therapy session while in a dissociative state. This allows them to process their thoughts and feelings in an entirely different kind of way.”
Related